Are Patients with ANCA-Associated Vasculitis Entered In Clinical Trials Representative of Patients Followed In Observational Cohorts?

被引：0

作者：

Pagnoux, Christian ^{[1
]}

Carette, Simon ^{[2
]}

Khalidi, Nader A. ^{[3
]}

Cuthberston, David ^{[4
]}

Fortin, Paul R. ^{[2
,5
]}

Hoffman, Gary S. ^{[6
]}

Langford, Carol A. ^{[7
]}

Monach, Paul A.

Mouthon, Luc ^{[9
]}

Seo, Philip ^{[10
]}

Specks, Ulrich ^{[11
]}

Ytterberg, Steven R. ^{[11
]}

Merkel, Peter A. ^{[8
]}

Guillevin, Loic ^{[12
]}

The Vcrc

机构：

[1] Univ Hlth Network, Toronto, ON, Canada

[2] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada

[3] McMaster Univ, Hamilton, ON, Canada

[4] Univ S Florida, Tampa, FL USA

[5] Univ Toronto, Toronto, ON, Canada

[6] Cleveland Clin Found A50, Cleveland, OH USA

[7] Cleveland Clin, Cleveland, OH 44106 USA

[8] Boston Univ, Sch Med, Boston, MA 02118 USA

[9] Hop Cochin, F-75674 Paris, France

[10] Johns Hopkins Vasculitis Ctr, Baltimore, MD USA

[11] Mayo Clin, Rochester, MN USA

[12] Cochin Univ Hosp, Paris, France

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2368

引用

页码：S923 / S923

页数：1

共 50 条

[1] Are patients with anti-ANCA-AAV entered into clinical trials representative of patients followed in observational cohorts?
Pagnoux, Christian
Carette, Simon
Khalidi, Nader A.
Cuthberston, David
Fortin, Paul
Hoffman, Gary
Langford, Carol
Monach, Paul A.
Mouthon, Luc
Seo, Phil
Specks, Ulrich
Ytterberg, Steven
Merkel, Peter A.
Guillevin, Loic
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 81 - 82
[2] Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts
Pagnoux, C.
Carette, S.
Khalidi, N. A.
Walsh, M.
Hiemstra, T. F.
Cuthbertson, D.
Langford, C.
Hoffman, G.
Koening, C. L.
Monach, P. A.
Moreland, L.
Mouthon, L.
Seo, P.
Specks, U.
Ytterbere, S.
Westman, K.
Hoglund, P.
Harper, L.
Flossmann, O.
Luqmani, R.
Savage, C.
Rasmussen, N.
de Groot, K.
Tesar, V.
Jayne, D.
Merkel, P. A.
Guillevin, L.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (02) : S77 - S83
[3] Clinical outcomes of ANCA-associated vasculitis in elderly patients
Ágnes Haris
Kálmán Polner
József Arányi
Henrik Braunitzer
Ilona Kaszás
István Mucsi
International Urology and Nephrology, 2014, 46 : 1595 - 1600
[4] Clinical outcomes of ANCA-associated vasculitis in elderly patients
Haris, Agnes
Polner, Kalman
Aranyi, Jozsef
Braunitzer, Henrik
Kaszas, Ilona
Mucsi, Istvan
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (08) : 1595 - 1600
[5] Avacopan for Patients with ANCA-associated Vasculitis
Rauen, Thomas
Kraemer, Stefan
Floege, Juergen
NEPHROLOGIE, 2022, 17 (02): : 117 - 118
[6] ANCA-ASSOCIATED VASCULITIS IN PATIENTS WITH SLE
Ziauddin, O.
Levine, J.
Cedillo-Couvert, E.
Setty, S.
Arami, S.
JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (04) : 873 - 874
[7] Morbidity in patients with ANCA-associated vasculitis
Harper, Lorraine
PRESSE MEDICALE, 2013, 42 (04): : 612 - 616
[8] MALIGNANCIES IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS TREATED WITHIN THE EUVAS TRIALS
Alamo, Beatriz Sanchez
Moi, Laura
Mahr, Alfred
Hruskova, Zdenka
Bajema, Ingeborg M.
Wallquist, Carin
Jayne, David
Westman, Kerstin W. A.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I826 - I826
[9] Pharmacokinetics of Rituximab and Clinical Outcomes in Patients with ANCA-Associated Vasculitis
Cornec, Divi
Kabat, Brian
Mills, John
Cheu, Melissa
Hummel, Amber
Schroeder, Darrell
Cascino, Matthew
Brunetta, Paul
Murray, David
Snyder, Melissa
Fervenza, Fernando
Hoffman, Gary S.
Kallenberg, Cees G. M.
Langford, Carol A.
Merkel, Peter A.
Monach, Paul A.
Seo, Philip
Spiera, Robert F.
St Clair, E. William
Stone, John H.
Barnidge, David
Specks, Ulrich
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[10] ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients
Cornec, Divi
Cornec-Le Gall, Emilie
Fervenza, Fernando C.
Specks, Ulrich
NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (10) : 570 - 579

← 1 2 3 4 5 →